Revenue
2023
2024
2025
CALLAN JMB INC. (CJMB)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $5.7M | $6.6M | $13.2M |
| Gross profit | $2.1M | $2.6M | $5.6M |
| Operating income | −$7.0M | −$2.3M | $2.2M |
| EBITDAderived | −$6.9M | −$2.1M | $2.3M |
| Net income | −$8.0M | −$2.3M | $2.2M |
| Basic EPSper diluted share | -$1.82 | -$0.87 | — |
| Diluted EPSper diluted share | -$1.82 | -$0.87 | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 20, 2026Form 4 | Croyle David JChief Medical Officer | BuyCommon Stock · indirect | 10.2K | $1.75 | $17.8K | 800.0K |
| Mar 6, 2026Form 4 | Croyle David JChief Medical Officer | BuyCommon Stock · indirect | 14.8K | $1.76 | $26.1K | 789.8K |
| Dec 30, 2025Form 4 | Dial GeraldDirector | BuyCommon Stock | 10.0K | $0.76 | $7.6K | 12.0K |
| Dec 30, 2025Form 4 | Dial GeraldDirector | BuyCommon Stock | 1.5K | $1.20 | $1.8K | 2.0K |
| Dec 30, 2025Form 4 | Dial GeraldDirector | BuyCommon Stock | 461 | $1.22 | $562.42 | 461 |